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With the world population predicted to reach almost 10 billion by 2050 there are a number of challenges 43 in sustainable management of finite resources. The rising demand for food requires improved 44 productivity of agricultural systems. One of the major burdens on the livestock industry is loss of 45 animals and decrease of production efficiency due to disease. Furthermore, it is important to improve 46 the health and welfare of animals by reducing and preferably preventing the effects of disease. Advances 47 in sequencing technology and genome editing techniques provide the unique opportunity to generate 48 animals with improved traits. In this review we will discuss the techniques currently applied to genetic 49 manipulation of livestock species and the efforts in making animals disease resistant or resilient. 50
The tools 51
In 1982 Plamiter and Brinster (1) set the stage for sequential advances in our ability to modify and 52 improve mammalian genomes for desirable traits. Whereas previous work by others showed that 53 foreign DNA fragments could be integrated into the genome of embryos by pronuclear microinjection 54 (PNI), their work demonstrated a functional application; introduction of a growth hormone gene into 55 mouse embryos resulted in rapid growth of the animals. Beyond utilizing cell-based approaches, early 56 genome modification was restricted to the injection of plasmids or gene fragments into the pronucleus 57 of embryos. More efficient integration of foreign DNA fragments into the target genome was 58 subsequently achieved using transposons or retroviral vectors (2, 3). Early specific edits in cells could 59 be achieved with homing endonucleases (HE), natural meganucleases, which introduce double strand 60 breaks (DSBs) at target recognition sites of 14-40bp (4). However, engineering of HEs has been 61 challenging and they are prone to off-target cutting, wherefore there are currently still very few in vivo 62 applications (5). The development of the zinc finger nuclease (ZFN) (6), the first genome editing tool, 63 increased the repertoire of programmed modifications, allowing precise cutting and repair to any target 64 genome. The intervening two decades have borne witness to the continued development of the editing 65 toolbox, with improvements in adaptability and efficiency, coupled with reduced costs and facile in-66 house assembly platforms, resulting in an almost exponential uptake of the technology in the last five 67 years ( Figure 1) . 68
Zinc Fingers (ZFs) are amongst the most well-characterised protein DNA binding domains (DBDs) found 69 in nature. Each ZF binds a triplet of nucleotides, with synthetic arrays of ZFs constructed to improve 70 specificity to a desired target sequence (typically 9-18 bases). ZFNs are chimeric enzymes created by 71 fusing a modular ZF array to the nuclease domain of the restriction enzyme FokI. composed of a repeated modular array, with each module having sequence preference for a single DNA 82 base (7). This simple 1-to-1, module-to-base, relationship makes design of functional synthetic DBDs 83 straight forward, and kits can be purchased to allow their assembly in a standard molecular biology lab 84 in less than two weeks. Typically designed to recognise 12-20 bases, arrays are fused with FokI to give 85 a TALE nuclease (TALEN), and, as with ZFNs, these are employed in pairs to allow FokI dimerization and 86 increase specificity. Two sequential modifications to the FokI domain further reduced the potential for 87 off-target cutting by both TALENs and ZFNs; conversion of the homodimer into an obligate heterodimer, 88 and conversion from a nuclease to a nickase by mutation of a catalytic domain (8). However, while 89
TALENs were certainly more widely utilised than ZFNs, they have since been superseded by the most 90 recent tool. 91
Developed from an innate bacterial antiviral mechanism, the latest addition to the genome editor 92 toolbox is the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated 93 (Cas) system. With target specificity directed by a short single-stranded RNA (ssRNA) molecule(s), this 94 represents a departure from the preceding genome editors that utilise a protein-based DBD. As with the 95 FokI nuclease domain, Cas nucleases lack innate sequence specificity but are instead guided to their 96 target site by Watson-Crick base pairing between their complexed ssRNA and the cognate DNA 97
sequence. This constitutes a major advantage for this tool; the Cas nuclease is not covalently fused to a 98 DBD so the same protein can be utilised to target multiple different target sites simply by combining it 99 with different combinations of ssRNA. Furthermore, while all of the reagents required can be produced 100 in almost any molecular biology lab, both the Cas nuclease and the ssRNA molecules can also be 101 purchased from multiple vendors. The ease with which reagents can be designed, coupled with 102 economical availability, has resulted in huge uptake of this tool and an explosion of publications in this 103 field. (9, 10) 104
105
The possibilities 106
Genome editors can break DNA at specific target sites; it is through the subsequent repair of these 107 breaks that scientists can introduce desired changes at the target locus. Most cell types preferentially 108 utilise the non-homologous end-joining (NHEJ) pathway, an error-prone process that typically results 109 in small insertions or deletions at the site of repair. By creating a DNA break in the coding sequence of a 110 gene, this form of repair often generates a frameshift mutation and thereby truncation of the encoded 111 protein or functional gene knockout (KO). Alternatively, by flooding the target cell with a DNA repair 112 template, it is possible to trigger the homology-directed repair (HDR) pathway. This allows the 113 introduction of precise sequence changes proximal to the cut site, ranging from single base changes to 114 the insertion of transgenes. Researchers commonly use synthetic single stranded oligodeoxynucleotides 115 to introduce small changes, or plasmid/dsDNA templates for larger insertions. Finally, by creating two 116 simultaneous breaks on a chromosome the intervening DNA sequence can be deleted; this approach can 117 be used to alter transcriptional profiles by removing regulatory elements, or to delete exons thereby 118 removing protein domains while leaving the remaining reading frame intact. (11) 119 As a result of the evolution of this technology and a greater understanding of how to harness its potential 120
we are now able to introduce extremely precise changes to the genome with greater accuracy and 121 efficiency than has ever been possible. We are now at a stage where we are limited more by our 122 imagination than the technology available. 123
The industry 124
The long history of livestock domestication has relied on the sequential selection of animals based on 125 desirable traits, with generational improvements in their ability to thrive in the varied habitats occupied 126 by the communities farming them. Traditionally, selective breeding focused on handling and 127 productivity traits, such as docility, feed conversion, and fertility, with modern breeding goals 128 incorporating animal health and welfare. Selecting for disease resistance and resilience is not only 129 important from an animal health and welfare perspective but has significant economic impacts. For 130 instance, it is estimated that endemic diseases incur added costs of €30-40 per slaughter pig in the 131 European Union, adding to up to €10.5bn per year ((12), EU28 2016 (13) relatively straightforward when traits can be measured accurately under normal husbandry conditions. 138
By contrast, disease susceptibility, or lack thereof, is a trait that is difficult to quantitatively assess as 139 exposure to pathogens within a population of animals is rarely uniform and the deliberate exposure of 140 large numbers of animals under experimental conditions is both ethically questionable and very 141 expensive (15). Even if such variance could be readily identified, the merit gains achieved by recent 142 breeding programmes may prove a barrier to propagation within a nucleus herd; the allelic variant 143 might be present in low abundance, recessive, or associated with animals that would otherwise be 144 considered of low merit. In this scenario genome editing offers an opportunity to contribute to the 145 natural breeding process, introducing newly identified genetic features into the progeny of elite nucleus 146 animals without negatively impacting other highly desirable traits (16). Such an approach could also 147 contribute to genetic improvement if relevant polymorphisms were identified in related breeds or even 148 other species ( Figure 2 ). As such, genome editors have great potential in allowing the introduction of 149 novel traits that improve animal welfare, increase production, reduce food waste in the production 150 chain, improve food security, and contribute to the economic security of small holder farmers. 151
The animals 152
Editing in cattle poses a significant challenge due to cost, small number of offspring, and long generation 153 time (9 months gestation, 12-18 months to reach sexual maturity). As a consequence, there is significant 154 pressure for editing techniques to be highly efficient to ensure intended offspring. While somatic cell 155 nuclear transfer (SCNT) of confirmed edited cells is often the preferred option (17, 18) cytoplasmic 156
microinjection (CPI) and PNI into in vitro fertilised oocytes have also been employed (19). While 157 generation of chimeras by microinjection of edited induced pluripotent stem cells (iPSCs) into 158
blastocysts has been demonstrated in multiple papers, so far no germline transmission was reported 159 (20, 21) . A potential future editing technique in cattle may also be the editing of spermatogonial stem 160 cells (SSCs). Long-term cultivation methods have been recently published and advances in 161 transplantation of these cells and sterile recipients could provide a promising avenue for generating 162 genome edited cattle (22, 23) . 163
Editing goats and sheep is less restricted than cattle; they are smaller, cheaper, and produce more 164 offspring and, with gestation times of 5 months and sexual maturity at 6-8 months, the generation times 165 are significantly lower. Oocytes can be collected from abattoir samples or by laparoscopic ovum pick-166 up, with in vitro fertilization (IVF) and microinjection of zygotes (24). In all ruminants blastocysts can 167 be re-implanted into a recipient, allowing testing embryo viability and genotype prior to the 168 implantation. Alternatively, small ruminants have also been generated by and goats by 169 sperm-mediated gene transfer (SMGT) (28). The generation of chimeric embryos from (non-edited) 170 iPSCs has been demonstrated in sheep (29), whilst in goats the generation of iPSCs has been reported, 171 no editing or chimeric integration has been demonstrated yet (30, 31) . 172
Pigs have several advantages over ruminants for genome modification; they have large litter sizes, a 173 short gestation of less than 4 months, and can reach sexual maturity at 5-6 months. While many groups 174 have successfully used SCNT to generate modified pigs, microinjection and transfer of zygotes is an 175 efficient alternative. As pigs are a multiparous species that self-limit the number of embryos they carry 176 to term, an excess of manipulated zygotes can be transferred to each recipient to improve pregnancy 177 rates. Zygotes are generally harvested from donor animals as polyspermy associated with IVF remains 178 a significant issue (32). Genome modified animals have been produced using a variety of techniques, 179 including SCNT and PNI and CPI of zygotes (comprehensive lists of modified animals can be found (33, 180 34)). Germline transmission has been demonstrated in chimeric animals generated from iPSCs (35, 181 36) .A variety of cultivation methods for SSCs have been described in pigs, whereas long-term cultivation 182 still remains a challenge (reviewed in (37)). Furthermore, genome edited, sterile recipients for the 183 transfer of (edited) SSCs have been described in pigs (38) . 184
Editing in chicken has proven challenging compared to mammals due to significant differences in 185 FAO lists honeybees as livestock as they are integral to many agricultural practices. Global impact of 210 honeybees as pollinators in crop production is significant (50, 51). Selective breeding in bees is 211 employed to select for hygienic, low disease burden colonies (52, 53). Edited or transgenic bees can be 212 generated by microinjection of embryos (54, 55). As has been the case in many agricultural species early 213 work involved the introduction of fluorescence markers into the genome (54). Application of genome 214 editors thus far has been to identify gene function rather than to address disease resistance (55). With 215 improvements in the understanding of the bee genome and more detailed association studies it is 216 anticipated that genome editing for disease resistance in bees is in the future (56). 217
The diseases 218
Mastitis has a huge impact in the dairy industries. In the US it is the most common disease in dairy cattle 219 resulting in estimated annual losses of $2bn. Globally, small ruminants also play an important role in 220 the dairy industries with mastitis conferring a significant economic burden. Staphylococcus aureus is the 221 most common pathogen to cause mastitis and there is a very low natural heritability of resilience to 222 infection. In ruminants a number of similar transgenic strategies have been employed by generating 223 animals producing enzymes inhibiting the growth of bacteria in the mammary gland. In cattle the 224 antibiotic lysostaphin was introduced by SCNT resulting in secreted protein in their milk, capable of 225 killing S.aureus (57). The milk from goats expressing human lysozyme was shown to inhibit the growth 226 of mastitis-causing bacteria and Pseudomonas fragi, responsible for the cold-spoilage of milk (58, 59). 227
Importantly, the growth of L. lactis, required for the making of processed dairy products, such as cheese, 228
was not inhibited. 229
Misfolding of the prion protein (PrP) is associated with neurogenerative diseases in many mammals. 230
The accumulation of misfolded PrP plaques results in bovine spongiform encephalopathy (BSE) in cattle 231 and scrapie in sheep and goats. A number of different groups have knocked out the PrP gene as a strategy 232 to circumvent such diseases. While a transgenic approach has been used to achieve this goal, application 233 of genome editors could be used streamline this process. In addition to value to the agricultural sector, 234 interest in PrP KO livestock extends to biopharmaceuticals, as this is considered an appropriate safety 235 measure of products destined for human applications (60-63). 236
Early efforts are ongoing to make ruminants resilient to Mannheimia (Pasteurella) haemolytica infection, 237 which causes epizootic pneumonia (shipping fever) and may also contribute to enzootic pneumonia in 238 calves and lambs as well as peritonitis in sheep. The pathogen can produce a cytotoxic leukotoxin, which 239 is largely responsible for the pathogenicity of the bacteria. In ruminants the leukotoxin binds to the 240 uncleaved signal peptide of the CD18 protein present on the cell surface leukocytes (64). In other 241 species, including mouse and human, the mature CD18 lacks the signal peptide as a result of proteolytic 242 processing. Based on the human sequence, ZFNs were used to introduce a single amino acid change. 243
Leukocytes from the resultant foetuses were resistant to cytotoxicity associated with M.haemolytica 244 leukotoxin (65). 245
Bovine tuberculosis (bTB) has a direct effect on productivity in cattle and buffalo, impacts international 246 trade, and poses a significant human health risk. Polymorphisms in the NRAMP1 gene, also known as 247 SLC11A1, in cattle have been associated with varying levels of resilience to bTB infection (66). 248 CRISPR/Cas9 was used for targeted insertion of an NRAMP1 variant associated with resilience to bTB 249 infection into the cattle genome. Ex vivo challenge of peripheral blood monocytes showed reduced 250 pathogen growth in exogenous NRAMP1 expressing cells. An in vivo study in the transgenic animals 251 reported diminished interferon response to TB infection but did not assess pathogen burden (67). 252
African Swine Fever Virus (ASFV) is a disease endemic to huge swathes of sub-Saharan Africa. Native 253 suid hosts, including the warthog, are resilient to the infection, while domestic pigs develop a lethal 254 haemorrhagic fever. Species-specific variation of the RELA, a component of the transcription factor NF-255 κb, between native and domestic suids were postulated to underlie this host genetic variance (68). Using 256 a ZFN pair with a plasmid template for HDR, researchers converted the encoded domestic pig protein 257 sequence to the warthog equivalent (69). Data to show resilience of the animals to ASFV infection has 258 yet to be reported. It is important to differentiate between disease resistance, the ability of an animal to 259 suppress the establishment and/or development of an infection, and disease resilience where an 260 infected host manages to maintain an acceptable level of productivity despite challenge pressure (70). 261
Should these pigs prove to be resilient to ASFV infection it is likely that their use may not be permitted 262 in many jurisdictions, since they could act as reservoirs of infection. However, in environments where 263 the disease is endemic use of such animals could be beneficial. 264
The most economically important pig disease worldwide is porcine reproductive and respiratory 265 syndrome (PRRS). In vitro experiments showed that entry of the causative agent of the disease, PRRS 266 virus (PRRSV), into host cells relies on two proteins, CD163 and CD169 (71). It was further 267 demonstrated that subdomain 5 of CD163 was essential for PRRSV entry (72) . Surprisingly, SCNT with 268 fibroblasts lacking CD169 resulted in pigs that were not resistant to PRRSV infection (73). Functional 269 CD163 KO animals were generated using a CRISPR/Cas9 to induce a NHEJ-mediated premature stop 270 codon (74). The CD163 KO animals were shown to be resistant to PRRSV infection both in vitro and in 271 vivo (75). CD163 has a wide variety of important biological functions in inflammation and immune 272 response. To retain these functions precise deletion of only CD163 subdomain 5 has been carried out. 273 Subdomain 5 is encoded by exon 7, which was excised from the genome using CPI of two guide RNAs 274 targeting the flanking intronic sequence. Cells from the resulting animals are resistant to PRRSV 275 infection and maintain their biological function (76). 276
Reactivation of endogenous retroviruses is a potential barrier to the use of livestock as tissue and organ 277 donors. Genome editors have been used to permanently inactivate porcine endogenous retrovirus in 278 pigs presenting a potential solution to this human health threat (77). 279
Avian influenza poses a significant threat to the global poultry industry and to human health, as zoonotic 280 transmission is frequently observed. The control of outbreaks requires the culling of infected and 281 neighbouring flocks and the implementation of strict biosecurity measure to prevent the further spread 282 of the virus. Transgenic chickens were generated by microinjection of eggs with retrovirus to 283 incorporate a small decoy RNA fragment under a U6 promoter into the chicken genome (78). The decoy 284 RNA fragment expressed in chickens interferes with the formation of infectious influenza particles, 285 thereby preventing spread to co-housed birds. This approach has yet to be evaluated in other species 286 susceptible to influenza. 287
Discussion and Outlook 288
Application of genome editors allows easy-to use, targeted strategies for genome modification in 289 livestock. To improve disease resistance traits, editing targets are identified by investigation of in vitro 290 host-pathogen interactions, species variation, or GWAS studies (Figure 3 ). The field of genome editors 291 is fast evolving and sequential improvements coupled with a better understanding of DSB repair 292 mechanisms will inevitably result in an expanded range of editing opportunities. Advances in delivery 293 techniques, such as editing gametes or spermatogonial, embryonic, or induced pluripotent stem cells, 294 will streamline the production of edited animals and make it applicable to a wider range of species. 295
Generating disease resistant animals will not only help to feed the world but also improve animal 296 welfare and aid in the reduction of antimicrobial use. 297
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